Compounds > 2-hydroxyhemopyrroline-5-one
Page last updated: 2024-09-05

2-hydroxyhemopyrroline-5-one and Acute Disease

2-hydroxyhemopyrroline-5-one has been researched along with Acute Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Graham, DJ; Moore, MR1
Gorchein, A1

Other Studies

2 other study(ies) available for 2-hydroxyhemopyrroline-5-one and Acute Disease

ArticleYear
Monopyrroles in porphyria, psychosis and lead exposure.
    The International journal of biochemistry, 1980, Volume: 12, Issue:5-6

    Topics: 5-Aminolevulinate Synthetase; Acute Disease; Aminolevulinic Acid; Animals; Heme Oxygenase (Decyclizing); Humans; Lead Poisoning; Leukocytes; Liver; Male; Porphyrias; Porphyrins; Psychotic Disorders; Pyrroles; Rats

1980
Urine concentration of 3-ethyl-5-hydroxy-4,5-dimethyl-delta 3-pyrrolin-2-one ('mauve factor') is not causally related to schizophrenia or to acute intermittent porphyria.
    Clinical science (London, England : 1979), 1980, Volume: 58, Issue:6

    Topics: Acute Disease; Adult; Chromatography, Gas; Female; Humans; Porphyrias; Pyrroles; Schizophrenia

1980